Article info

Download PDFPDF

Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease

Authors

  • Thanh Duc Hoang Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USAMedicine, Uniformed Services University of the Health Sciences F Edward Hebert School of Medicine, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Nguyen T Nguyen Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Eva Chou Ophthalmology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Mohamed KM Shakir Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USAMedicine, Uniformed Services University of the Health Sciences F Edward Hebert School of Medicine, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Thanh Duc Hoang; tdhdthanh{at}gmail.com
View Full Text

Citation

Hoang TD, Nguyen NT, Chou E, et al
Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease

Publication history

  • Accepted April 17, 2021
  • First published May 10, 2021.
Online issue publication 
May 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.